Advertisements


Novartis (NVS) Gets FDA Nod for Label Expansion of Promacta

Zacks.....»»

Category: topSource: redinewsNov 19th, 2018

Novartis (NVS) Gets FDA Nod for Label Expansion of Promacta

Novartis (NVS) obtains FDA approval for the label expansion of Promacta. The CHMP also issues a positive opinion for the label expansion of Kisqali. Novartis AG NVS announced that the FDA has expanded the label of Promacta (eltrombopag) .....»»

Category: smallbizSource: nytNov 19th, 2018

Novartis Gets Positive CHMP Opinion for Drugs, Biosimilar

Novartis (NVS) gets positive CHMP opinion for a label expansion of Gilenya, gene therapy, and a biosimilar of Neulasta. Novartis AG NVS announced that the Committee for Medi.....»»

Category: personnelSource: nytSep 24th, 2018

Novartis" (NVS) Kisqali Gets FDA Nod for Label Expansion

Novartis' (NVS) breast cancer drug, Kisqali, gets FDA appro.....»»

Category: worldSource: nytJul 19th, 2018

J&J"s Blood Cancer Drugs Succeed in Label Expansion Studies

Zacks.....»»

Category: topSource: redinewsDec 5th, 2018

Piper gets positive feedback on Seattle Genetics label expansion

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 27th, 2018

AMAG"s Label Expansion of Lead Products Raises Share Price

Sha.....»»

Category: futuresSource: nasdaqNov 27th, 2018

AMAG"s Label Expansion of Lead Products Raises Share Price

AMAG's (AMAG) label expansion efforts for Feraheme and Makena are encouraging. Share price of AMAG Pharmaceuticals, Inc. AMAG has increased 37.9% year to date, against the industry’s decline of 19.0%.AMAG h.....»»

Category: smallbizSource: nytNov 26th, 2018

Roche, AbbVie Get FDA Approval for Venclexta Label Expansion

Zacks.....»»

Category: topSource: redinewsNov 22nd, 2018

Glaxo Seeks Label Expansion of Nucala in Pediatric Patients

Glaxo (GSK) submits sBLA to the FDA seeking label expansion of its asthma drug, Nucala, in pediatric patients in the United States. GlaxoSmithKline plc GSK announced the submission of a su.....»»

Category: dealsSource: nytNov 20th, 2018

AbbVie"s HCV Drug Mavyret Succeeds in Label Expansion Study

Zacks.....»»

Category: topSource: redinewsNov 14th, 2018

AbbVie"s HCV Drug Mavyret Succeeds in Label Expansion Study

AbbVie's (ABBV) Mavyret demonstrates high virologic cure rates in a study evaluating .....»»

Category: worldSource: nytNov 14th, 2018

Tesaro, Clovis Rally on FDA Priority Review for Lynparza sNDA

PARP inhibitor makers get a boost following priority review for AstraZeneca???s (AZN) label expansion application for Lynparza as a first-line maintenance treatment for ovarian cancer. Shares of TESARO, Inc. TSRO and Clovis Oncology.....»»

Category: worldSource: nytNov 14th, 2018

AstraZeneca"s Lynparza Gets Priority Review in 1st Line Use

AstraZeneca (AZN) and partner Merck's sNDA looking for label expansion of Lynparza in the first-line setting gets FDA's priority review. .....»»

Category: dealsSource: nytNov 13th, 2018

Novartis: EC approval for Cosentyx label update to include dosing flexibility

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 26th, 2018

Roche"s Hemlibra Receives FDA Approval for Label Expansion

Roche (RHHBY) obtains the FDA approval for the label expansion of Hemlibra for the treatment of adults and children suffering haemophilia A without factor VIII inhibitors. .....»»

Category: worldSource: nytOct 5th, 2018

Allergan Eyes Vraylar Label Expansion, FDA Accepts sNDA

FDA accepts Allergan's (AGN) sNDA for label expansion of its schizophrenia drug, Vraylar (cariprazine) to include.....»»

Category: dealsSource: nytSep 27th, 2018

Bristol-Myers" Sprycel Seeks Label Expansion in the U.S.

Zacks.....»»

Category: topSource: redinewsAug 31st, 2018

Regeneron"s Eylea Gets FDA Nod for Wet AMD as a 12-Week Dose

Regeneron Pharmaceuticals (REGN) gets the FDA approval for the label expansion of its lead drug, Eylea as a treatment for wet AMD with a modified 12-week dosing sch.....»»

Category: personnelSource: nytAug 20th, 2018

DexCom selloff on Libre label expansion overdone, says JPMorgan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 27th, 2018

Kroger hopes to slash into P&G's Gillette razor blade business

The new line is an expansion of Kroger's formidable private label business that gen.....»»

Category: topSource: usatodayJul 27th, 2018